Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: VolitionRx Ltd. VNRX

VolitionRx Ltd. (VNRX) Cancer Diagnostic Tool Yield Hope amid Global Epidemic of Prostate Cancer

Life sciences company VolitionRx is engaged in the development of blood-based diagnostic tests for different types of cancer. Demonstrating significant headway with its NuQ® assays, VolitionRx recently released data from a pilot study of the test to diagnose prostate cancer. … Continue reading

Posted in VolitionRx Ltd. VNRX | Leave a comment

VolitionRx Ltd. (VNRX) Reports Noteworthy Results from Pilot Study of Its Diagnosis Tests for Prostate Cancer

Earlier this week, VolitionRx reported significant results from a pilot study of use of its NuQ® tests for diagnosis of prostate cancer. The results of the trial showed that the tests were able to detect approximately 80 percent of prostate … Continue reading

Posted in VolitionRx Ltd. VNRX | Leave a comment

VolitionRx Ltd. (VNRX) Has Experienced Management at Helm

VolitionRx is a publicly traded life sciences company focused on the development of blood-based diagnostics for different types of cancer. It believes that current diagnostic measures are too costly or inadequate, and to that end it is developing superior-grade, more … Continue reading

Posted in VolitionRx Ltd. VNRX | Leave a comment

VolitionRx, Ltd. (VNRX) Blood-based Biomarker Tests Show Great Promise for Cancer Screening and Treatment Management

For those of you who are interested in investing in speculative growth with biotech stocks, the potential of a test or drug that can be brought to market makes all the difference. I have been watching and researching a company … Continue reading

Posted in VolitionRx Ltd. VNRX | Leave a comment

VolitionRx Ltd. (VNRX) Completes $3 Million Private Placement

VolitionRx, a life sciences company, announced today that it has completed a private placement with select new and existing accredited investors and received $3 million in gross proceeds from the transaction. Lake Street Capital Markets, LLC served as the transaction’s … Continue reading

Posted in VolitionRx Ltd. VNRX | Leave a comment

VolitionRx Ltd. (VNRX) to Revolutionize Cancer Diagnosis with Superior Early Detection

Early detection of cancer increases the chance of survival and/or curative treatment. While this is true of all cancers, the World Health Organization puts emphasis on the value of early diagnosis in cancers of the breast, cervix, mouth, larynx, colon, … Continue reading

Posted in VolitionRx Ltd. VNRX | Leave a comment

VolitionRx Ltd. (VNRX) Pioneering Cancer Diagnostics for Growing Colorectal Cancer Incidences

VolitionRx is a publicly traded life sciences company that is developing innovative solutions for blood-based diagnostics for different types of cancers. The company believes that current diagnostics techonologies are inadequate, so is focusing its efforts on developing earlier, more cost-effective … Continue reading

Posted in VolitionRx Ltd. VNRX | Leave a comment

VolitionRx Ltd. (VNRX) Nucleosomics® Technology Shows Potential as Game Changer in Colorectal Cancer Screening

VolitionRx is a biotech small-cap dedicated to the development of blood-based diagnostic tests for different types of cancer, with an initial focus on colorectal cancer, the second deadliest cancer in the United States. After the age of 50, healthcare experts … Continue reading

Posted in VolitionRx Ltd. VNRX | Leave a comment

VolitionRx Ltd. (VNRX) Dubbed “Bright Biotech” by Wall St. Cheat Sheet Contributor

VolitionRx was one of two companies recently highlighted in an article published in Wall St. Cheat Sheet that emphasized the long-term impact of positive news and/or achievements in the biotechnology industry. “One way to offset the current market uncertainty is … Continue reading

Posted in VolitionRx Ltd. VNRX | Leave a comment

VolitionRX Ltd. (VNRX) Focused on Making Cancer Detection Simple and Routine

The early detection of cancer is considered crucial in developing a truly effective approach to dealing with the disease. There are, of course, many types of cancers, but early detection, before symptoms develop, could have a dramatic effect on the … Continue reading

Posted in VolitionRx Ltd. VNRX | Leave a comment